We first examined the CoV-AbDab database of validated monoclonal anti-SARS-CoV-2 antibodies and compared them to published bulk BCR repertoires of four COVID-19 patients, as well as to a healthy control bulk BCR repertoire. Here, BCR is linked to COVID-19.